Clinical Tests of HIV Vaccine Developed with mRNA Started

Caused by a virus called HIV AIDS is one of the deadliest diseases humanity has faced. This disease, which has killed millions of people since its first appearance in the 1980s, weakens the immune system and damages the body’s resistance. That’s why scientists have been trying to develop a vaccine against the disease for many years.

Now there has been an important development in this regard. US-based pharmaceutical company that also develops a COVID-19 vaccine modern and the International AIDS Vaccine Initiative for the HIV vaccine they developed. to human trials announced the start. Just like in the COVID vaccine, this vaccine is also in the news. mRNA technology was used.

Tests will be performed on 56 healthy adults

According to the statements made by the authorities, clinical trials of the vaccine started on Thursday. Experts reported that the first dose was administered to volunteers from the George Washington University School of Medicine in Washington, the capital of the USA.

Phase 1 studies 56 Noting that there will be HIV negative adults, the authorities stated that 48 of these people will receive one or two doses of mRNA vaccine. It was later reported that a reminder dose would be administered to 32 of this group. It was stated that only the reminder dose would be applied to the remaining eight people. In addition, Moderna, the entire group for six months monitor immune responses to see if the vaccine is effective. at the molecular level announced that it plans to investigate.

This vaccine, which was developed thanks to the mRNA technology used in the COVID-19 vaccine; part of the immune system B cells, known as bnAb and thought to be effective against the disease to antibodies conversion is planned. In addition, it is stated that this technology can be used in vaccines to be developed against other deadly diseases such as malaria and may lead to important developments in the medical world.